Fields of Application
New hope for visual field loss: The Eyetronic Therapy has been developed for patients suffering from a progressive visual field loss due to glaucoma or other diseases of the optic nerve.
New hope for visual field loss: The Eyetronic Therapy has been developed for patients suffering from a progressive visual field loss due to glaucoma or other diseases of the optic nerve.
New hope for visual field loss: The Eyetronic Therapy has been developed for patients suffering from a progressive visual field loss due to glaucoma or other diseases of the optic nerve.
The therapy is based on the knowledge that tissue is not completely destroyed when the optic nerve is damaged. Retinal ganglion cells may survive, but are malfunctioning. By applying gentle alternating pulses which are individually adapted to the patient, the Eyetronic Therapy stimulates the metabolism of the neurons in order to restore their function and to stop further cell degeneration. The efficacy of this non-invasive therapy has been proven in clinical studies.1 Since 2014 the treatment is offered in selected centers.
The therapy is based on the knowledge that tissue is not completely destroyed when the optic nerve is damaged. Retinal ganglion cells may survive, but are malfunctioning. By applying gentle alternating pulses which are individually adapted to the patient, the Eyetronic Therapy stimulates the metabolism of the neurons in order to restore their function and to stop further cell degeneration. The efficacy of this non-invasive therapy has been proven in clinical studies.1 Since 2014 the treatment is offered in selected centers.
The Eyetronic® System is CE marked and available in selected European markets.
The Eyetronic® Therapy and the Eyetronic® System are not yet available in the United States of America.